Home/Pipeline/Generic Drug Portfolio

Generic Drug Portfolio

CNS, Cardiovascular, Anti-infective

ANDA / MarketedCommercial

Key Facts

Indication
CNS, Cardiovascular, Anti-infective
Phase
ANDA / Marketed
Status
Commercial
Company

About China SXT Pharmaceuticals

China SXT Pharmaceuticals (NASDAQ: SXTC) is a China-based specialty pharmaceutical company with a dual-mission to modernize Traditional Chinese Medicine (TCM) and produce generic drugs. The company has established an integrated operational model, managing R&D, manufacturing, and commercialization in-house, primarily targeting high-prevalence conditions in its domestic market. Its strategy hinges on capitalizing on government support for TCM integration into the healthcare system and the ongoing demand for affordable generic pharmaceuticals, though it faces significant execution and competitive risks.

View full company profile